NCT04392102 A Study of Niraparib in Patients With Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT04383977 Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT04383210 Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT04377087 Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer Status TERMINATED Phase PHASE2
NCT04375956 Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients Status UNKNOWN Phase PHASE2
NCT04368130 SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care Status WITHDRAWN Phase NA
NCT04354246 COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT04352439 Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy Status COMPLETED Phase PHASE4
NCT04337632 Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT04332653 NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04330716 Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers Status COMPLETED Phase NA
NCT04330040 Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer Status COMPLETED Phase PHASE4
NCT04300699 Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer Status UNKNOWN Phase NA
NCT04295577 Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR Status COMPLETED Phase N/A
NCT04294927 TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention Status RECRUITING Phase NA